Lv6
2014 积分 2023-06-06 加入
Emerging Role of the p53 Pathway in Modulating NK Cell–Mediated Immunity
7天前
已完结
Emerging Role of the p53 Pathway in Modulating NK Cell–Mediated Immunity
12天前
已关闭
p53 at the crossroads of tumor immunity
6个月前
已完结
Antitumor Effects of β-Elemene Through Inducing Autophagy-Mediated Apoptosis in Ewing Sarcoma Family Tumor Cells
1年前
已完结
Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
1年前
已完结
Design and Synthesis of New Triazole‐Benzimidazole Derivatives as Potential PRMT5 Inhibitors
5天前
已采纳
TRAP1 drives smooth muscle cell senescence and promotes atherosclerosis via HDAC3-primed histone H4 lysine 12 lactylation
5天前
已采纳
Transcriptome Profiling of Tiller Buds Provides New Insights into PhyB Regulation of Tillering and Indeterminate Growth in Sorghum1
6天前
已采纳
KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma
6天前
已采纳
Controlled oxygen doping in highly dispersed Ni-loaded g-C3N4 nanotubes for efficient photocatalytic H2O2 production
6天前
已采纳
Immunogenicity and safety of booster CYD-TDV dengue vaccine after alternative primary vaccination schedules in healthy individuals aged 9–50 years: a randomised, controlled, phase 2, non-inferiority study
6天前
已采纳
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial
6天前
已采纳
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
6天前
已采纳
皖公网安备34019202002308
